Bausch Health
BHC
#3480
Rank
C$4.46 B
Marketcap
$12.08
Share price
-2.11%
Change (1 day)
29.87%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$3.61

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.74. In 2022 the company made an earnings per share (EPS) of -$0.87 an increase over its 2021 EPS that were of -$3.74.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.61312.3%
2022-$0.87-76.64%
2021-$3.7468.45%
2020-$2.22-68.91%
2019-$7.15-57.11%
2018-$16.67-272.22%
2017$9.68-199.29%
2016-$9.75798.7%
2015-$1.08-128.31%
2014$3.83-204.62%
2013-$3.66602.7%
2012-$0.52-171.15%
2011$0.73-143.96%
2010-$1.67-206.57%
2009$1.56-11.2%
2008$1.762.46%
2007$1.72-7.58%
2006$1.86-14.29%
2005$2.1754%
2004$1.41-500%
2003-$0.35-141.67%
2002$0.85-4.76%
2001$0.89-175%
2000-$1.18-268%
1999$0.7014.94%
1998$0.6120.83%
1997$0.5153.83%
1996$0.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.41-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.38-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA